Milauskas Eye Institute Medical Group Ii Inc is categorized under Surgeons in Palm Springs, CA .
Milauskas Eye Institute Medical Group Ii Inc was established in 0, and today employs 1 to 4, earning Unknown per year. This is a Surgeons business, which does work in the B2C market, and is classified as a Surgeons, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Albert Milauskas at the company’s branch by writing to 555 East Tachevah Drive E101, Palm Springs, California CA 92262 or by phoning (760) 327-1561. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Milauskas Eye Institute Medical Group Ii Inc |
Contact Person: | Albert Milauskas |
Address: | 555 East Tachevah Drive E101, Palm Springs, California 92262 |
Phone Number: | (760) 327-1561 |
Website Address: | milauskas-eye.com |
Annual Revenue (USD): | Unknown |
Location Type: | Branch |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Surgeons |
SIC Code: | 8011 |
NAICS Code: | 621111 |
Share This Business: |
Milauskas Eye Institute Medical Group Ii Inc was started in 0 to provide professional Surgeons under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Albert Milauskas for inquiries that concern Milauskas Eye Institute Medical Group Ii Inc by calling the company number (760) 327-1561, as your correspondence is most welcome. Additionally, the physical location of the branch of Milauskas Eye Institute Medical Group Ii Inc can be found at the coordinates 33.83744,-116.541411 as well as the street address 555 East Tachevah Drive E101 in Palm Springs, California 92262.
For its online presence, you may visit Milauskas Eye Institute Medical Group Ii Inc’s website at milauskas-eye.com and engage with its social media outlets through on Twitter and on Facebook.